Answers are grounded in this paper and cite their sources.
An assumed difference in diffusibility of various sulfonamide drugs into the cerebrospinal fluid has been widely invoked to explain the low cerebro- spinal fluid levels of certain drugs, especially sulfathiazole.In a preliminary report (1), it was pointed out that certain facts regarding the dis- tribution of these drugs in the body may be ex- plained by their binding to proteins in the body fluids.In this paper, there is presented a brief non- mathematical discussion of the concepts of dif- fusibility and permeability, as they relate to the distribution of substances in the body fluids, as- sumed to be separated by a series of semipermeable membranes.According to the principles here described, it is deduced from the observed dis- tribution of sulfonamide drugs that these mole- cules are bound to plasma proteins.Experiments are reported which confirm this expectation.Further experiments are reported concerning the effect on this binding of pH, temperature, and fractionation of the proteins, the purpose of which is to furnish information concerning the nature of the binding, and to insure that the findings are applicable to conditions in the body.Therapeutic implications are briefly discussed. PHYSICO-CHEMICAL CONSIDERATIONSThe use of the term "diffusibility" by the clini- cian is sometimes incompatible with its physical definition, and is confused with the concept of permeability.Diffusion in a solution refers to the process of spontaneous thermal agitation of the molecules, which causes a net transfer from re- gions of higher to regions of lower concentration without mixing by flow.
No takes yet. Share an insight, caveat, or question.
Bernard D. Davis (1943) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: